Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Fig 5 - by Elizabeth A. Moore (18083377)

Subjects:

Fig 10 - by Sana Khalid (132742)

Subjects:

Oral administration of PEITC reduces food intake during refeeding following fasting. by Miho Yagi (5921252)

LAMP1 decreased within MoDCs infected with <i>P. gingivalis</i> expressing Mfa1. by Ahmed R. El-Awady (697683)

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)

Focal adhesion kinase phosphorylation levels within the optic nerve head decrease steadily after intraocular pressure elevation. by Shandiz Tehrani (3365900)

Oral administration of PEITC stimulates leptin signaling in the hypothalamus. by Miho Yagi (5921252)

Establishment of HIV latency correlates with elevated amounts of AcH4 and Brd4 but drastically decreased AcH3 content on viral LTR. by Zichong Li (5131241)

<i>Kpna1</i> KO mice show decreased anxiety-like behavior in the elevated plus maze. by Koki Sakurai (11690201)

cART raised plasma total triglyceride and total cholesterol levels in HIV-Tg rats—Attenuation by high Mg diet. by Lama ElZohary (6250859)

Mean and standard deviation values of <i>p</i> and <i>q</i> distributions shown in Fig 5, and generated with a rolling, overlapping time window of 252 days. by Héctor Raúl Olivares-Sánchez (13014866)

Relationship between a simplified SCOPE score at start of treatment with anakinra and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

<i>WNT10A</i>^–/–KO skin wound showing reduced fibrosis/fibrogenesis associated with the decreased expression of stromagenesis-related genes. by Ke-Yong Wang (234594)

The decrease of <i>USP28</i> protein levels induced by Ni ions or hypoxia contributed to c-Myc degradation in A549 cells. by Qin Li (36669)

Characterization of Tet-On hTCEpi-ALDH3A1 cell lines. by Vindhya Koppaka (845151)

PRV and HSV-1 employ US3 to decrease Bclaf1 in a proteasome-dependent manner. by Chao Qin (119135)

TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)